These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

410 related articles for article (PubMed ID: 25204610)

  • 1. Long-term effects of tocilizumab therapy for refractory uveitis-related macular edema.
    Mesquida M; Molins B; Llorenç V; Sainz de la Maza M; Adán A
    Ophthalmology; 2014 Dec; 121(12):2380-6. PubMed ID: 25204610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TWENTY-FOUR MONTH FOLLOW-UP OF TOCILIZUMAB THERAPY FOR REFRACTORY UVEITIS-RELATED MACULAR EDEMA.
    Mesquida M; Molins B; Llorenç V; Hernández MV; Espinosa G; Sainz de la Maza M; Adán A
    Retina; 2018 Jul; 38(7):1361-1370. PubMed ID: 28520640
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tocilizumab treatment for refractory uveitis-related cystoid macular edema.
    Adán A; Mesquida M; Llorenç V; Espinosa G; Molins B; Hernández MV; Pelegrín L
    Graefes Arch Clin Exp Ophthalmol; 2013 Nov; 251(11):2627-32. PubMed ID: 23893042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IL6-Receptor Tocilizumab in Refractory and Noninfectious Uveitic Cystoid Macular Edema: Multicenter Study of 25 Patients.
    Vegas-Revenga N; Calvo-Río V; Mesquida M; Adán A; Hernández MV; Beltrán E; Valls Pascual E; Díaz-Valle D; Díaz-Cordovés G; Hernandez-Garfella M; Martínez-Costa L; Calvo I; Atanes A; Linares LF; Modesto C; González-Vela C; Demetrio-Pablo R; Aurrecoechea E; Cordero M; Domínguez-Casas LC; Atienza-Mateo B; Martín-Varillas JL; Loricera J; Palmou-Fontana N; Hernández JL; González-Gay MA; Blanco R
    Am J Ophthalmol; 2019 Apr; 200():85-94. PubMed ID: 30660771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patients.
    Díaz-Llopis M; Salom D; Garcia-de-Vicuña C; Cordero-Coma M; Ortega G; Ortego N; Suarez-de-Figueroa M; Rio-Pardo MJ; Fernandez-Cid C; Fonollosa A; Blanco R; Garcia-Aparicio AM; Benitez-Del-Castillo JM; Olea JL; Arevalo JF
    Ophthalmology; 2012 Aug; 119(8):1575-81. PubMed ID: 22525047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tocilizumab in Uveitic Macular Edema Refractory to Previous Immunomodulatory Treatment.
    Deuter CME; Zierhut M; Igney-Oertel A; Xenitidis T; Feidt A; Sobolewska B; Stuebiger N; Doycheva D
    Ocul Immunol Inflamm; 2017 Apr; 25(2):215-220. PubMed ID: 26731514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. intravitreal tumor necrosis factor inhibitors in the treatment of refractory diabetic macular edema: a pilot study from the Pan-American Collaborative Retina Study Group.
    Wu L; Hernandez-Bogantes E; Roca JA; Arevalo JF; Barraza K; Lasave AF
    Retina; 2011 Feb; 31(2):298-303. PubMed ID: 21099452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of intravitreal bevacizumab compared with intravitreal and posterior sub-tenon triamcinolone acetonide for treatment of uveitic cystoid macular edema.
    Bae JH; Lee CS; Lee SC
    Retina; 2011 Jan; 31(1):111-8. PubMed ID: 20856170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Interleukin-6 Receptor Tocilizumab for Severe Juvenile Idiopathic Arthritis-Associated Uveitis Refractory to Anti-Tumor Necrosis Factor Therapy: A Multicenter Study of Twenty-Five Patients.
    Calvo-Río V; Santos-Gómez M; Calvo I; González-Fernández MI; López-Montesinos B; Mesquida M; Adán A; Hernández MV; Maíz O; Atanes A; Bravo B; Modesto C; Díaz-Cordovés G; Palmou-Fontana N; Loricera J; González-Vela MC; Demetrio-Pablo R; Hernández JL; González-Gay MA; Blanco R
    Arthritis Rheumatol; 2017 Mar; 69(3):668-675. PubMed ID: 27696756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-TNF-α agents for refractory cystoid macular edema associated with noninfectious uveitis.
    Schaap-Fogler M; Amer R; Friling R; Priel E; Kramer M
    Graefes Arch Clin Exp Ophthalmol; 2014 Apr; 252(4):633-40. PubMed ID: 24366669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of macular edema and impact on visual acuity in uveitis associated with juvenile idiopathic arthritis.
    de Boer J; Steijaert A; van den Bor R; Stellato R; Ossewaarde-van Norel J
    Ocul Immunol Inflamm; 2015 Feb; 23(1):67-73. PubMed ID: 24410459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravitreal adalimumab for refractory uveitis-related macular edema.
    Androudi S; Tsironi E; Kalogeropoulos C; Theodoridou A; Brazitikos P
    Ophthalmology; 2010 Aug; 117(8):1612-6. PubMed ID: 20378179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic interventions for macular diseases show characteristic effects on near and distance visual function.
    Munk M; Kiss C; Huf W; Sulzbacher F; Bolz M; Sayegh R; Eisenkölbl S; Simader C; Schmidt-Erfurth U
    Retina; 2013 Oct; 33(9):1915-22. PubMed ID: 23584693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of tocilizumab in two patients with anti-TNF-alpha refractory uveitis.
    Muselier A; Bielefeld P; Bidot S; Vinit J; Besancenot JF; Bron A
    Ocul Immunol Inflamm; 2011 Oct; 19(5):382-3. PubMed ID: 21970668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Safety and efficacy of subconjunctival triamcinolone injections in the management of uveitic macular edema: retrospective study of thirty-one cases].
    Bleriot A; Couret C; Le Meur G; Lebranchu P; Weber M
    J Fr Ophtalmol; 2014 Oct; 37(8):599-604. PubMed ID: 25199486
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dexamethasone intravitreal implant in the treatment of persistent uveitic macular edema in the absence of active inflammation.
    Cao JH; Mulvahill M; Zhang L; Joondeph BC; Dacey MS
    Ophthalmology; 2014 Oct; 121(10):1871-6. PubMed ID: 24907061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravitreal bevacizumab as first local treatment for uveitis-related choroidal neovascularization: long-term results.
    Julián K; Terrada C; Fardeau C; Cassoux N; Français C; LeHoang P; Bodaghi B
    Acta Ophthalmol; 2011 Mar; 89(2):179-84. PubMed ID: 21348964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optical coherence tomography-guided ranibizumab injection for cystoid macular edema in well-controlled uveitis: twelve-month outcomes.
    Reddy AK; Cabrera M; Yeh S; Davis JL; Albini TA
    Retina; 2014 Dec; 34(12):2431-8. PubMed ID: 25170857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of Functional and Anatomic Outcomes in Patients with Diabetic Macular Edema Treated with Ranibizumab.
    Sophie R; Lu N; Campochiaro PA
    Ophthalmology; 2015 Jul; 122(7):1395-401. PubMed ID: 25870079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.